Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use VELETRI safely and effectively. See full prescribing information for VELETRI. VELETRI® (epoprostenol) for injection, for intravenous use Initial U.S. Approval: 1995
Medication labelWhy this: Advisory · dailymed-prescription
VELETRI is indicated for the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) to improve exercise capacity. Studies establishing effectiveness included predominantly patients with NYHA Functional Class III–IV symptoms and etiologies of idiopathic or heritable PAH or PAH associated with connective tissue diseases.
- generic_name
- epoprostenol
- product_names
- epoprostenol
- ndc
- 66215-402, 66215-403, 66215-403-01, 66215-402-01
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en